Profile: Smith & Nephew PLC (SN.L)

SN.L on London Stock Exchange

1,173.00GBp
24 Dec 2014
Price Change (% chg)

84.00p (+7.71%)
Prev Close
1,089.00p
Open
1,180.00p
Day's High
1,195.00p
Day's Low
1,155.00p
Volume
3,070,637
Avg. Vol
2,792,455
52-wk High
1,198.00p
52-wk Low
850.00p

Search Stocks
Smith & Nephew plc is a global medical devices business operating in the markets for orthopaedic reconstruction and trauma, endoscopy (which includes arthroscopic procedures referred to as sports medicine) and advanced wound management. It operates in three segments: Orthopaedics, Endoscopy and Advanced Wound Management. It operates on a worldwide basis and has distribution channels in over 90 countries. Orthopaedic reconstruction implants include hip, knee and shoulder joints, as well as ancillary products, such as bone cement and mixing systems used in cemented reconstruction joint surgery. Endoscopy business develops and commercialises endoscopic (minimally invasive surgery) techniques, educational programmes and services. Advanced Wound Management business offers a range of products from initial wound bed preparation through to full wound closure. In May 2012, it acquired Kalypto Medical, Inc. In May 2014, the Company acquired ArthroCare Corporation.

Company Address

Smith & Nephew PLC

15 Adam Street
LONDON   ENG   WC2N 6LA
P: +4420.74017646
F: +4420.79303353

Search Stocks